|Articles|October 25, 2012
Risk of VTE Increased in New Users of Drospirenone
A retrospective cohort study of more than a half million new users of hormonal contraception shows that drospirenone is associated with a higher risk of thrombotic events than contraceptives containing low-dose estrogen.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Telehealth expands maternal-fetal medicine access, with Jeffrey Chapa, MD
2
Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition
3
HIV screening, PrEP counseling get stronger ACOG recommendation
4
Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG
5